These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

598 related articles for article (PubMed ID: 22768077)

  • 1. Prevention of birch pollen-related food allergy by mucosal treatment with multi-allergen-chimers in mice.
    Hoflehner E; Hufnagl K; Schabussova I; Jasinska J; Hoffmann-Sommergruber K; Bohle B; Maizels RM; Wiedermann U
    PLoS One; 2012; 7(6):e39409. PubMed ID: 22768077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal treatment with a recombinant hypoallergenic derivative of the major birch pollen allergen Bet v 1 prevents allergic sensitization and airway inflammation in mice.
    Wiedermann U; Herz U; Baier K; Vrtala S; Neuhaus-Steinmetz U; Bohle B; Dekan G; Renz H; Ebner C; Valenta R; Kraft D
    Int Arch Allergy Immunol; 2001 Sep; 126(1):68-77. PubMed ID: 11641608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A recombinant allergen chimer as novel mucosal vaccine candidate for prevention of multi-sensitivities.
    Wild C; Wallner M; Hufnagl K; Fuchs H; Hoffmann-Sommergruber K; Breiteneder H; Scheiner O; Ferreira F; Wiedermann U
    Allergy; 2007 Jan; 62(1):33-41. PubMed ID: 17156339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of antigen-specific T- and B-cell responses by intranasal or oral administration of recombinant bet v 1, the major birch pollen allergen, in a murine model of type I allergy.
    Wiedermann U; Jahn-Schmid B; Bohle B; Repa A; Renz H; Kraft D; Ebner C
    J Allergy Clin Immunol; 1999 Jun; 103(6):1202-10. PubMed ID: 10359907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.
    Subbarayal B; Schiller D; Möbs C; de Jong NW; Ebner C; Reider N; Bartel D; Lidholm J; Pfützner W; Gerth van Wijk R; Vieths S; Bohle B
    Allergy; 2013 Nov; 68(11):1377-86. PubMed ID: 24053565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro analysis of birch-pollen-associated food allergy by use of recombinant allergens in the basophil activation test.
    Erdmann SM; Sachs B; Schmidt A; Merk HF; Scheiner O; Moll-Slodowy S; Sauer I; Kwiecien R; Maderegger B; Hoffmann-Sommergruber K
    Int Arch Allergy Immunol; 2005 Mar; 136(3):230-8. PubMed ID: 15713985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral exposure to Mal d 1 affects the immune response in patients with birch pollen allergy.
    Geroldinger-Simic M; Kinaciyan T; Nagl B; Baumgartner-Durchschlag U; Huber H; Ebner C; Lidholm J; Bartel D; Vieths S; Jahn-Schmid B; Bohle B
    J Allergy Clin Immunol; 2013 Jan; 131(1):94-102. PubMed ID: 22921871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nonallergenic birch pollen allergy vaccine consisting of hepatitis PreS-fused Bet v 1 peptides focuses blocking IgG toward IgE epitopes and shifts immune responses to a tolerogenic and Th1 phenotype.
    Marth K; Breyer I; Focke-Tejkl M; Blatt K; Shamji MH; Layhadi J; Gieras A; Swoboda I; Zafred D; Keller W; Valent P; Durham SR; Valenta R
    J Immunol; 2013 Apr; 190(7):3068-78. PubMed ID: 23440415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The major birch pollen allergen Bet v 1 induces different responses in dendritic cells of birch pollen allergic and healthy individuals.
    Smole U; Radauer C; Lengger N; Svoboda M; Rigby N; Bublin M; Gaier S; Hoffmann-Sommergruber K; Jensen-Jarolim E; Mechtcheriakova D; Breiteneder H
    PLoS One; 2015; 10(1):e0117904. PubMed ID: 25635684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal IgE antibodies against birch pollen allergens: novel tools for biological characterization and standardization of allergens.
    Kaul S; Scheurer S; Danz N; Schicktanz S; Vieths S; Hoffmann A
    J Allergy Clin Immunol; 2003 Jun; 111(6):1262-8. PubMed ID: 12789227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E. coli Nissle 1917 is a safe mucosal delivery vector for a birch-grass pollen chimera to prevent allergic poly-sensitization.
    Sarate PJ; Heinl S; Poiret S; Drinić M; Zwicker C; Schabussova I; Daniel C; Wiedermann U
    Mucosal Immunol; 2019 Jan; 12(1):132-144. PubMed ID: 30242254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cor a 1-reactive T cells and IgE are predominantly cross-reactive to Bet v 1 in patients with birch pollen-associated food allergy to hazelnut.
    Hofmann C; Scheurer S; Rost K; Graulich E; Jamin A; Foetisch K; Saloga J; Vieths S; Steinbrink K; Adler HS
    J Allergy Clin Immunol; 2013 May; 131(5):1384-92.e6. PubMed ID: 23246018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal co-application of lactic acid bacteria and allergen induces counter-regulatory immune responses in a murine model of birch pollen allergy.
    Repa A; Grangette C; Daniel C; Hochreiter R; Hoffmann-Sommergruber K; Thalhamer J; Kraft D; Breiteneder H; Mercenier A; Wiedermann U
    Vaccine; 2003 Dec; 22(1):87-95. PubMed ID: 14604575
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Aglas L; Bethanis A; Chrusciel P; Stolz F; Gruen M; Jaakkola UM; Jongejan L; Yatkin E; Van Ree R
    Front Immunol; 2020; 11():2118. PubMed ID: 33013894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bet v 1142-156 is the dominant T-cell epitope of the major birch pollen allergen and important for cross-reactivity with Bet v 1-related food allergens.
    Jahn-Schmid B; Radakovics A; Lüttkopf D; Scheurer S; Vieths S; Ebner C; Bohle B
    J Allergy Clin Immunol; 2005 Jul; 116(1):213-9. PubMed ID: 15990797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bet v 1, the major birch pollen allergen, initiates sensitization to Api g 1, the major allergen in celery: evidence at the T cell level.
    Bohle B; Radakovics A; Jahn-Schmid B; Hoffmann-Sommergruber K; Fischer GF; Ebner C
    Eur J Immunol; 2003 Dec; 33(12):3303-10. PubMed ID: 14635038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bet v 1--a Trojan horse for small ligands boosting allergic sensitization?
    Asam C; Batista AL; Moraes AH; de Paula VS; Almeida FC; Aglas L; Kitzmüller C; Bohle B; Ebner C; Ferreira F; Wallner M; Valente AP
    Clin Exp Allergy; 2014 Aug; 44(8):1083-93. PubMed ID: 24979350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pollen-related food allergy: cloning and immunological analysis of isoforms and mutants of Mal d 1, the major apple allergen, and Bet v 1, the major birch pollen allergen.
    Son DY; Scheurer S; Hoffmann A; Haustein D; Vieths S
    Eur J Nutr; 1999 Aug; 38(4):201-15. PubMed ID: 10502033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Dau c 1 in three different patterns of carrot-induced asthma.
    Moreno-Ancillo A; Gil-Adrados AC; Cosmes PM; Domínguez-Noche C; Pineda F
    Allergol Immunopathol (Madr); 2006; 34(3):116-20. PubMed ID: 16750122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oesophagostomum dentatum extract modulates T cell-dependent immune responses to bystander antigens and prevents the development of allergy in mice.
    Schabussova I; Ul-Haq O; Hoflehner E; Akgün J; Wagner A; Loupal G; Joachim A; Ruttkowski B; Maizels RM; Wiedermann U
    PLoS One; 2013; 8(7):e67544. PubMed ID: 23844022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.